ESAB vs WST · P/E 27, rev $2.84B vs P/E 35, rev $1.72B
ESAB Corp (ESAB) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
ESAB Corp (ESAB) is a metal fabrication company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported ESAB revenue for 2025-12-31 was $2.84B. Net income was $226.8M. Revenue was up 3.7% from 2024-12-31 to 2025-12-31. ESAB currently screens at market cap $7.88B and trailing P/E 26.6.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
ESAB currently screens at market cap $7.88B and trailing P/E 26.6. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the ESAB and WST stock pages for the full models.
Not investment advice.